Korean Journal of Biological Psychiatry (생물정신의학)

The Korean Society of Biological Psychiatry (대한생물정신의학회)
권호 표지

Comparison of Depressive Symptoms between Social Anxiety Disorder and Panic Disorder

사회불안장애와 공황장애에 동반된 우울증상의 특성 비교

  • Kim, Sun-Young (Department of Psychiatry, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Lim, Se-Won (Department of Psychiatry, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Shin, Young-Chul (Department of Psychiatry, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Shin, Dong-Won (Department of Psychiatry, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Oh, Kang-Seob (Department of Psychiatry, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
  • 김선영 (성균관대학교 의과대학 강북삼성병원 정신건강의학교실) ;
  • 임세원 (성균관대학교 의과대학 강북삼성병원 정신건강의학교실) ;
  • 신영철 (성균관대학교 의과대학 강북삼성병원 정신건강의학교실) ;
  • 신동원 (성균관대학교 의과대학 강북삼성병원 정신건강의학교실) ;
  • 오강섭 (성균관대학교 의과대학 강북삼성병원 정신건강의학교실)
  • Received : 2015.10.02
  • Accepted : 2015.10.21
  • Published : 2015.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives The principal aim of the present study was to investigate the characteristic depressive symptoms in patients with social anxiety disorder (SAD) and panic disorder in comparison to patients with depressive disorder. Methods This study included 132 patients with SAD, 128 panic disorder and 64 depressive disorder (major depressive disorder, dysthymia etc.) patients without comorbid psychiatric disorders. The Beck Depressive Inventory (BDI) is used to measure depressive symptoms. We divided BDI into three categories originally described by Shafer AB, including negative attitude toward self, performance impairment, and somatic symptoms. We compared the depressive symptoms of SAD, panic disorder and depressive disorder by using ANOVA. Results Negative attitude toward self was noticeable in SAD (SAD $0.54{\pm}0.23$, panic disorder $0.41{\pm}0.17$, depressive disorder $0.46{\pm}0.11$, p < 0.001). Performance impairment and somatic symptoms were remarkable in panic disorder than in SAD and depressive disorder (performance impairment : SAD $0.39{\pm}0.21$, panic disorder $0.44{\pm}0.14$, depressive disorder $0.40{\pm}0.09$, p = 0.009 ; somatic symptoms : SAD $0.07{\pm}0.10$, panic disorder $0.15{\pm}0.12$, depressive disorder $0.14{\pm}0.08$, p < 0.001). Conclusions The results facilitate an approach to optimal treatment for patients with comorbidity of anxiety disorder and depression.

Keywords

References

  1. Kaufman J, Charney D. Comorbidity of mood and anxiety disorders. Depress Anxiety 2000;12 Suppl 1:69-76. https://doi.org/10.1002/1520-6394(2000)12:1+<69::AID-DA9>3.0.CO;2-K
  2. Aderka IM, Hofmann SG, Nickerson A, Hermesh H, Gilboa- Schechtman E, Marom S. Functional impairment in social anxiety disorder. J Anxiety Disord 2012;26:393-400. https://doi.org/10.1016/j.janxdis.2012.01.003
  3. Stein MB, Kean YM. Disability and quality of life in social phobia: epidemiologic findings. Am J Psychiatry 2000;157:1606-1613. https://doi.org/10.1176/appi.ajp.157.10.1606
  4. Schneier FR, Heckelman LR, Garfinkel R, Campeas R, Fallon BA, Gitow A, et al. Functional impairment in social phobia. J Clin Psychiatry 1994;55:322-331.
  5. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19. https://doi.org/10.1001/archpsyc.1994.03950010008002
  6. Brown TA, Barlow DH. Comorbidity among anxiety disorders: implications for treatment and DSM-IV. J Consult Clin Psychol 1992; 60:835-844. https://doi.org/10.1037/0022-006X.60.6.835
  7. Davidson JR, Hughes DL, George LK, Blazer DG. The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area Study. Psychol Med 1993;23:709-718. https://doi.org/10.1017/S0033291700025484
  8. Gelernter CS, Uhde TW, Cimbolic P, Arnkoff DB, Vittone BJ, Tancer ME, et al. Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study. Arch Gen Psychiatry 1991;48:938-945. https://doi.org/10.1001/archpsyc.1991.01810340070009
  9. Lecrubier Y, Weiller E. Comorbidities in social phobia. Int Clin Psychopharmacol 1997;12 Suppl 6:S17-S21.
  10. Nelson EC, Grant JD, Bucholz KK, Glowinski A, Madden PAF, Reich W, et al. Social phobia in a population-based female adolescent twin sample: co-morbidity and associated suicide-related symptoms. Psychol Med 2000;30:797-804. https://doi.org/10.1017/S0033291799002275
  11. Noyes R Jr, Moroz G, Davidson JR, Liebowitz MR, Davidson A, Siegel J, et al. Moclobemide in social phobia: a controlled dose-response trial. J Clin Psychopharmacol 1997;17:247-254. https://doi.org/10.1097/00004714-199708000-00002
  12. Schneier FR, Saoud JB, Campeas R, Fallon BA, Hollander E, Coplan J, et al. Buspirone in social phobia. J Clin Psychopharmacol 1993;13:251-256.
  13. Van Ameringen M, Mancini C, Styan G, Donison D. Relationship of social phobia with other psychiatric illness. J Affect Disord 1991;21:93-99. https://doi.org/10.1016/0165-0327(91)90055-W
  14. Ledley DR, Huppert JD, Foa EB, Davidson JR, Keefe FJ, Potts NL. Impact of depressive symptoms on the treatment of generalized social anxiety disorder. Depress Anxiety 2005;22:161-167. https://doi.org/10.1002/da.20121
  15. Erwin BA, Heimberg RG, Juster H, Mindlin M. Comorbid anxiety and mood disorders among persons with social anxiety disorder. Behav Res Ther 2002;40:19-35. https://doi.org/10.1016/S0005-7967(00)00114-5
  16. Leon AC, Portera L, Weissman MM. The social costs of anxiety disorders. Br J Psychiatry Suppl 1995;(27):19-22.
  17. Mendlowicz MV, Stein MB. Quality of life in individuals with anxiety disorders. Am J Psychiatry 2000;157:669-682. https://doi.org/10.1176/appi.ajp.157.5.669
  18. Katon WJ. Clinical practice. Panic disorder. N Engl J Med 2006;354:2360-2367. https://doi.org/10.1056/NEJMcp052466
  19. Clayton PJ. The comorbidity factor: establishing the primary diagnosis in patients with mixed symptoms of anxiety and depression. J Clin Psychiatry 1990;51 Suppl:35-39.
  20. Cassano GB, Perugi G, Musetti L, Akiskal HS. The nature of depression presenting concomitantly with panic disorder. Compr Psychiatry 1989;30:473-482. https://doi.org/10.1016/0010-440X(89)90076-X
  21. Charney DS, Heninger GR, Price LH, Breier A. Major depression and panic disorder: diagnostic and neurobiological relationships. Psychopharmacol Bull 1986;22:503-511.
  22. Reich JH. DSM-III personality disorders and the outcome of treated panic disorder. Am J Psychiatry 1988;145:1149-1152. https://doi.org/10.1176/ajp.145.9.1149
  23. Scheibe G, Albus M. Prospective follow-up study lasting 2 years in patients with panic disorder with and without depressive disorders. Eur Arch Psychiatry Clin Neurosci 1994;244:39-44. https://doi.org/10.1007/BF02279810
  24. Vollrath M, Koch R, Angst J. The Zurich Study. IX. Panic disorder and sporadic panic: symptoms, diagnosis, prevalence, and overlap with depression. Eur Arch Psychiatry Neurol Sci 1990;239:221-230. https://doi.org/10.1007/BF01738576
  25. Buller R, Maier W, Benkert O. Clinical subtypes in panic disorder: their descriptive and prospective validity. J Affect Disord 1986;11:105-114. https://doi.org/10.1016/0165-0327(86)90015-7
  26. Vollrath M, Angst J. Outcome of panic and depression in a sevenyear follow-up: results of the Zurich study. Acta Psychiatr Scand 1989;80:591-596. https://doi.org/10.1111/j.1600-0447.1989.tb03031.x
  27. Hamilton M. The clinical distinction between anxiety and depression. Br J Clin Pharmacol 1983;15 Suppl 2:165S-169S. https://doi.org/10.1111/j.1365-2125.1983.tb05862.x
  28. Lamers F, van Oppen P, Comijs HC, Smit JH, Spinhoven P, van Balkom AJ, et al. Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry 2011;72:341-348. https://doi.org/10.4088/JCP.10m06176blu
  29. Bittner A, Goodwin RD, Wittchen HU, Beesdo K, Hofler M, Lieb R. What characteristics of primary anxiety disorders predict subsequent major depressive disorder? J Clin Psychiatry 2004;65:618-626; quiz 730. https://doi.org/10.4088/JCP.v65n0505
  30. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M. I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59 Suppl 20:22-33; quiz 34-57.
  31. Yoo SW. Recent trends of anxiety disorders and the introduction of MINI. Jeju: GSK Satellite Symposium;2001.
  32. Yoo SW, Kim YS, Noh JS, Oh KS, Kim CH, Namkoong K, et al. Validity of Korean Version of the Mini-International Neuropsychiatric Interview. Anxiety and Mood 2006;2:50-55.
  33. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571. https://doi.org/10.1001/archpsyc.1961.01710120031004
  34. Han HM, Yeom TH, Shin YW, Kim KH, Yoon DJ, Jung KJ. A Standardization Study of Beck Depression Inventory in Korea. J Korean Neuropsychiatr Assoc 1986;25:487-500.
  35. Shafer AB. Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung. J Clin Psychol 2006;62:123-146. https://doi.org/10.1002/jclp.20213
  36. Lee SH, Chung KS. A clinical study of social phobia(1). J Korean Neuropsychiatr Assoc 1984;23:111-116.
  37. Choi HM, Kim NH, Lim SW, Oh KS. Gender differences in the symptomatic characteristics of Social Phobia patients in one university hospital. Anxiety and Mood 2008;4:62-67.
  38. Wittchen HU, Stein MB, Kessler RC. Social fears and social phobia in a community sample of adolescents and young adults: prevalence, risk factors and co-morbidity. Psychol Med 1999;29:309-323. https://doi.org/10.1017/S0033291798008174
  39. Weinstock LS. Gender differences in the presentation and management of social anxiety disorder. J Clin Psychiatry 1999;60 Suppl 9:9-13. https://doi.org/10.4088/JCP.v60n0104
  40. Gokalp PG, Tükel R, Solmaz D, Demir T, Kiziltan E, Demir D, et al. Clinical features and co-morbidity of social phobics in Turkey. Eur Psychiatry 2001;16:115-121. https://doi.org/10.1016/S0924-9338(01)00548-X
  41. Raguram R, Bhide AV. Patterns of phobic neurosis: a retrospective study. Br J Psychiatry 1985;147:557-560. https://doi.org/10.1192/bjp.147.5.557
  42. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, et al. The cross-national epidemiology of panic disorder. Arch Gen Psychiatry 1997;54:305-309. https://doi.org/10.1001/archpsyc.1997.01830160021003
  43. Ehlers A, Margraf J, Roth WT. Selective information processing, interoception, and panic attacks. Panic and Phobias 1988;2:129-148.
  44. Simon NM, Otto MW, Korbly NB, Peters PM, Nicolaou DC, Pollack MH. Quality of life in social anxiety disorder compared with panic disorder and the general population. Psychiatr Serv 2002;53:714-718. https://doi.org/10.1176/appi.ps.53.6.714
  45. Lee KM, Oh YH, Oh KS. Comparison of disabilities in patients with social phobia and panic disorder. J Korean Neuropsychiatr Assoc 2005;44:232-237.
  46. Green AC, Hunt C, Stain HJ. The delay between symptom onset and seeking professional treatment for anxiety and depressive disorders in a rural Australian sample. Soc Psychiatry Psychiatr Epidemiol 2012;47:1475-1487. https://doi.org/10.1007/s00127-011-0453-x
  47. Hollifield M, Katon W, Skipper B, Chapman T, Ballenger JC, Mannuzza S, et al. Panic disorder and quality of life: variables predictive of functional impairment. Am J Psychiatry 1997;154:766-772. https://doi.org/10.1176/ajp.154.6.766
  48. Noyes R Jr, Reich JH, Suelzer M, Christiansen J. Personality traits associated with panic disorder: change associated with treatment. Compr Psychiatry 1991;32:283-294. https://doi.org/10.1016/0010-440X(91)90076-O
  49. Mavissakalian M, Hamann MS. DSM-III personality disorder in agoraphobia. II. Changes with treatment. Compr Psychiatry 1987;28:356-361. https://doi.org/10.1016/0010-440X(87)90072-1
  50. Green MA, Curtis GC. Personality disorders in panic patients: response to termination of antipanic medication. J personality Disorders 1988;2:303-314. https://doi.org/10.1521/pedi.1988.2.4.303